"There are other prescription medications that may be more affordable, but still safe and effective for lowering insulin levels and driving weight loss," he added
TRIUMPH Program Eli Lillys Phase 3 clinical development program for Retatrutide, consisting of multiple trials across obesity, type 2 diabetes, osteoarthritis, sleep apnea, liver disease, and cardiovascular outcomes
GLP-1s dont just nudge your body toward weight loss
Holm, L
Some healthcare providers may consider prescribing both medications simultaneously in select cases, particularly when patients have not achieved adequate weight loss with semaglutide alone or when attempting to transition from one medication to another
Phase III studies are expected to start in the third quarter of 2002